{"id":"https://openalex.org/W4281777815","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21546","title":"Association of baseline corticosteroid treatment with outcomes for patients (pts) with BRAF-mutant melanoma brain metastases (MBMs) in COMBI-MB treated with dabrafenib and trametinib (DT).","display_name":"Association of baseline corticosteroid treatment with outcomes for patients (pts) with BRAF-mutant melanoma brain metastases (MBMs) in COMBI-MB treated with dabrafenib and trametinib (DT).","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281777815","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21546"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.e21546","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21546","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21546","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001606920","display_name":"James S. Wilmott","orcid":"https://orcid.org/0000-0002-6750-5244","observed_orcids":["https://orcid.org/0000-0002-6750-5244"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"James S. Wilmott","raw_affiliation_strings":["Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia, Sydney, Australia;","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045927706","display_name":"Hiya Banerjee","orcid":"https://orcid.org/0000-0003-1158-0330","observed_orcids":["https://orcid.org/0000-0003-1158-0330"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiya Banerjee","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034402801","display_name":"Philippe Sa\u00efag","orcid":"https://orcid.org/0000-0002-6500-3507","observed_orcids":["https://orcid.org/0000-0002-6500-3507"]},"institutions":[{"id":"https://openalex.org/I4210133069","display_name":"H\u00f4pital Ambroise-Par\u00e9","ror":"https://ror.org/03j6rvb05","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210133069"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Saiag","raw_affiliation_strings":["Dermatology Department, Ambroise Par\u00e9 Hospital, APHP, Versailles University \u2013 Paris-Saclay, Boulogne-Billancourt, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department, Ambroise Par\u00e9 Hospital, APHP, Versailles University \u2013 Paris-Saclay, Boulogne-Billancourt, France;","institution_ids":["https://openalex.org/I4210133069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100713900","display_name":"Caroline Robert","orcid":"https://orcid.org/0000-0002-9493-0238","observed_orcids":["https://orcid.org/0000-0002-9493-0238"]},"institutions":[{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Robert","raw_affiliation_strings":["Gustave Roussy and Paris-Saclay University, Villejuif-Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy and Paris-Saclay University, Villejuif-Paris, France;","institution_ids":["https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061072132","display_name":"Jean\u2010Jacques Grob","orcid":"https://orcid.org/0000-0002-0667-153X","observed_orcids":["https://orcid.org/0000-0002-0667-153X","https://orcid.org/0000-0002-1014-4062"]},"institutions":[{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Jacques Grob","raw_affiliation_strings":["Aix-Marseille University, CHU Timone, Marseille, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aix-Marseille University, CHU Timone, Marseille, France;","institution_ids":["https://openalex.org/I21491767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070576000","display_name":"Georgina Venetia Long","orcid":"https://orcid.org/0000-0001-8894-3545","observed_orcids":["https://orcid.org/0000-0001-8894-3545"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2800079252","display_name":"Royal North Shore Hospital","ror":"https://ror.org/02gs2e959","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800079252"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Georgina V. Long","raw_affiliation_strings":["Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia;","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2800079252","https://openalex.org/I4210118383"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"e21546","last_page":"e21546"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.8457000255584717,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.8457000255584717,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.12950000166893005,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-mutant-melanoma","display_name":"BRAF-mutant melanoma","score":0.9490000009536743},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.9319999814033508},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":0.8169999718666077},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":1.0},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/intracranial-progression-free-survival","display_name":"intracranial progression-free survival","score":0.9399999976158142},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8059999942779541},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.8889999985694885},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/extracranial-metastasis","display_name":"extracranial metastases","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.927979052066803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6271297931671143},{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.6230998635292053},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5411043167114258},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49112555384635925},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.4836207926273346},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.47275620698928833},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4679029881954193},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.4320727586746216},{"id":"https://openalex.org/C2777318727","wikidata":"https://www.wikidata.org/wiki/Q409464","display_name":"Lactate dehydrogenase","level":3,"score":0.4278803765773773},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4184332489967346},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4183650314807892},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.38564804196357727},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3489139676094055},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32382726669311523},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2976698875427246},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2837381660938263},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.15796709060668945},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.15456834435462952},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.12002259492874146},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.e21546","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21546","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21546","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310958180","https://openalex.org/W4319795175","https://openalex.org/W4386485275","https://openalex.org/W3089312114","https://openalex.org/W4391027495","https://openalex.org/W1532851266","https://openalex.org/W2739116172","https://openalex.org/W2752107913","https://openalex.org/W4321374218","https://openalex.org/W2753627940"],"abstract_inverted_index":{"e21546":[0],"Background:":[1],"The":[2,409],"COMBI-MB":[3,91,388],"trial":[4,429],"showed":[5],"that":[6],"DT":[7],"was":[8,182,260,287,357],"safe":[9],"for":[10,214,380,420,426],"BRAF-mutant":[11],"melanoma":[12],"pts":[13,37,366,381],"with":[14,38,71,161,187,262,289,307,360,368,382,390],"MBMs.":[15,383,427],"However,":[16],"slightly":[17],"lower":[18],"intracranial":[19,26],"response":[20],"rates":[21],"(ICRR)":[22],"and":[23,54,74,140,148,322,393],"markedly":[24],"shorter":[25,234],"progression-free":[27],"survival":[28,76],"(PFS)":[29],"were":[30,80,163,174],"observed":[31],"than":[32],"in":[33,36,52,89,281,364,370,377,387,402],"previous":[34,374],"trials":[35,379,404],"extracranial":[39,406],"metastases":[40],"(EM)":[41],"only.":[42,408],"In":[43],"order":[44],"to":[45,55,68,135,138,373,413],"understand":[46],"the":[47,90,183,421],"basis":[48],"of":[49,64,109,112,116,122,142,171,210,326,344,396,405,411,423],"this":[50],"difference":[51],"outcomes,":[53],"inform":[56],"patient":[57],"management,":[58],"we":[59],"performed":[60,81],"post":[61],"hoc":[62],"analyses":[63],"baseline":[65,128,181,305],"clinical":[66,362],"features":[67,94],"identify":[69],"associations":[70,375],"ICRR,":[72],"PFS,":[73],"overall":[75],"(OS).":[77],"Methods:":[78],"Analyses":[79],"on":[82,189,202,217,227,249,342,399],"all":[83,151],"patients":[84,215,389],"(n":[85,204,219,254,269],"=":[86,193,198,205,220,247,255,270,303,320,351],"125)":[87],"enrolled":[88],"trial.":[92],"Baseline":[93,354],"included":[95],"age,":[96],"gender,":[97],"ECOG":[98,323,338,394],"performance":[99],"status":[100,325,339,395],"(PS),":[101],"BRAF":[102,251,266],"genotype":[103,253,392],"(V600E":[104],"vs":[105],"V600":[106,267],"other),":[107],"number":[108],"MBM,":[110],"sum":[111],"longest":[113],"diameters":[114],"(SLD)":[115],"MBMs,":[117],"maximum":[118],"MBM":[119,144,365],"size,":[120],"presence":[121,141],"EM,":[123],"serum":[124],"lactate":[125],"dehydrogenase":[126],"(LDH),":[127],"corticosteroid":[129,355],"treatment,":[130],"prior":[131],"treatments":[132,425],"(systemic,":[133],"radiotherapy":[134],"brain,":[136],"surgery":[137],"brain),":[139],"uncontrolled":[143],"symptoms.":[145],"Univariate":[146],"(UV)":[147],"multivariate":[149],"(MV,":[150],"variables":[152],"entered)":[153],"analysis":[154],"utilized":[155],"Cox":[156],"proportional":[157],"hazards":[158],"modeling.":[159],"Associations":[160],"ICRR":[162,188,209],"identified":[164],"using":[165],"logistic":[166],"regression":[167],"modelling.":[168],"P":[169,246,279,302,319,350],"values":[170],">":[172],"0.05":[173],"considered":[175],"significant.":[176],"Results:":[177],"Corticosteroids":[178],"treatment":[179,306,356],"at":[180],"only":[184],"factor":[185],"associated":[186,261,288,359],"either":[190],"UV":[191,284],"(p":[192,197],"0.021)":[194],"or":[195],"MV":[196,343],"0.048)":[199],"analysis.":[200],"Pts":[201,229],"corticosteroids":[203,231,308,412],"13)":[206],"had":[207,233],"an":[208],"39%":[211],"versus":[212,238,265,294,311,330],"63%":[213],"not":[216],"steroids":[218],"63)":[221],"(OR":[222],"0.323,":[223],"95%":[224],"CI":[225,244,277,299,316,335,348],"0.105-0.996":[226],"MV).":[228,282],"receiving":[230],"also":[232],"PFS":[235,264],"[median":[236],"4.3":[237],"6.2":[239],"months":[240],"(mos),":[241],"HR":[242,275,297,314,333],"1.931,":[243],"1.061-3.513,":[245],"0.031":[248],"MV].":[250],"V600E":[252],"104,":[256],"median":[257,272],"5.9":[258],"months)":[259],"improved":[263],"other":[268],"21,":[271],"4.2":[273],"months,":[274,296,313,332],"0.565,":[276],"0.321-0.996,":[278],"=0.0483":[280],"On":[283],"analysis,":[285],"OS":[286,345],"elevated":[290],"LDH":[291],"(median":[292,309,328],"10.6":[293],"12.7":[295],"1.595,":[298],"1.045-":[300],"2.434,":[301],"0.0305),":[304],"9.3":[310],"13.5":[312],"1.642,":[315],"1.037-":[317],"2.598,":[318],"0.0343),":[321],"PS":[324],"0":[327],"18.9":[329],"8.2":[331],"0.435,":[334],"0.285-0.664).":[336],"Only":[337],"remained":[340],"significant":[341],"(HR":[346],"0.441,":[347],"0.249-0.779,":[349],"0.0048).":[352],"Conclusions:":[353],"independently":[358],"inferior":[361],"outcomes":[363,386],"treated":[367],"D+T":[369],"COMBI-MB,":[371],"similar":[372,400],"reported":[376],"immunotherapy":[378],"Likewise,":[384],"superior":[385],"BRAFV600E":[391],"zero":[397],"builds":[398],"observations":[401],"COMB-D/V":[403],"disease":[407],"use":[410],"treat":[414],"symptoms":[415],"is":[416],"a":[417],"major":[418],"obstacle":[419],"efficacy":[422],"systemic":[424],"Clinical":[428],"information:":[430],"NCT02039947.":[431]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-13T00:00:00"}